Updated:
National Institutes of Health
The National Institutes of Health deploys $47.8B annually into biomedical research — the largest such allocation globally.
National Institutes of Health
The National Institutes of Health was founded in 1887 as a one-room bacteriology laboratory on Staten Island. Today the agency is the dominant global funder of biomedical research, operating 27 institutes and centers from its Bethesda, Maryland headquarters. Approximately 83% of its budget flows to extramural investigators via competitive grants, while 11% supports its own 6,000 scientists in intramural labs on the 300-acre main campus. NIH's deployment shapes the entire biomedical economy. Its National Cancer Institute alone obligates roughly $6.9 billion annually, funding programs from early-stage investigator awards to SPORE translational oncology centers. The agency allocates across therapeutics, diagnostics, genomics, neuroscience, and infectious disease — notable recipients include Moderna's mRNA platform, Recursion's AI-driven drug discovery, and the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership with AbbVie, AstraZeneca, and Eli Lilly. Geographic coverage is inherently national: every US state hosts NIH-funded researchers, with dense clusters at institutions like Harvard, Stanford, the Broad Institute, and Johns Hopkins. The foundation managing NIH's gift fund assets appears modest alongside its annual appropriations. The Foundation for the National Institutes of Health (FNIH), created by Congress in 1990, operates adjacent vehicles including the Biomarkers Consortium and the Partnership for Accelerating Cancer Therapies (PACT) — a $220 million collaboration with 12 pharmaceutical companies. Monica Bertagnolli took the directorship in November 2023, joining from the National Cancer Institute and Dana-Farber Cancer Center. Her arrival coincided with a renewed push for open-access publishing requirements across all NIH-funded work. Structurally, NIH is an executive-branch agency whose funding demands annual congressional appropriation — a governance model that makes its capital both the most stable and most politically contingent in scientific funding. No other research allocator globally combines extramural grantmaking at this scale with an operating division of 6,000 multidisciplinary researchers and a 200-bed Clinical Center testing roughly 1,600 protocols per year.
General information
Firm type
Endowment
Year founded
1887
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bethesda
Corporate office
Bethesda, MD, United States
Principals
Monica Bertagnolli
Director
Sector focus
Frequently asked questions
How does NIH allocate its capital between internal and external research?
Roughly 83% of the annual budget goes to extramural research via competitive grants to universities, hospitals, and independent labs, per the agency's own budget breakdowns. About 11% funds intramural research conducted by NIH's own scientists on the Bethesda campus. The remainder covers administration, facilities, and oversight.
Who sets NIH's research priorities and funding levels?
Annual funding levels are determined by congressional appropriations. The NIH Director and institute leadership set scientific priorities, advised by the Advisory Committee to the Director and institute-level councils predominantly composed of external academic scientists. The White House Office of Management and Budget and the HHS Secretary also shape budget requests before they reach Congress.
Does NIH take equity or receive royalties from the discoveries it funds?
NIH itself does not take equity. Under the Bayh-Dole Act, universities and small businesses that receive NIH grants retain title to inventions and may license them, paying a share of royalties to the inventor and institution. NIH can retain a royalty-free license for government use. The FNIH is a separate 501(c)(3) that manages philanthropic donations and public-private partnerships without mingling with appropriated funds.
How does NIH's Clinical Center operate, and can external researchers access it?
The NIH Clinical Center in Bethesda is a 200-bed research hospital operating roughly 1,600 clinical research protocols in a typical year. It treats patients enrolled in NIH-led studies — almost exclusively for research, not community care. External researchers can collaborate with NIH intramural investigators to access it, but they cannot independently schedule patients there.
What is the Foundation for the NIH, and how does it interact with the main agency?
The Foundation for the National Institutes of Health (FNIH) is a Congressionally-authorized 501(c)(3) that raises private philanthropic funds and manages public-private consortia like the Biomarkers Consortium and PACT. It is legally separate, enabling NIH to collaborate with pharmaceutical and biotech firms under structures that appropriated funds cannot easily support. Partnerships like PACT pooled $220 million from 12 pharmaceutical companies alongside NCI funding.
Can private investment firms co-invest alongside NIH grants?
NIH does not co-invest in the venture-capital sense. A biotech startup receiving an SBIR or STTR grant may have concurrent venture backing, but the grant is a non-dilutive award, not an equity investment. The FNIH, by contrast, does structure cost-sharing consortia where corporate partners and NIH each contribute to a pooled research budget.
What is NIH's role in drug repurposing and translational science?
The National Center for Advancing Translational Sciences (NCATS), one of NIH's 27 institutes, explicitly targets the 'valley of death' between basic research and clinical application. NCATS' drug repurposing program has screened thousands of approved drugs against novel disease targets, though final development and commercialization remain with for-profit partners.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: